Clinical Trial Update: Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck [EARLY_Phase 1]

View source ↗

Summary

This early-phase window-of-opportunity trial tests the combination of nivolumab and tadalafil in patients with head and neck squamous cell carcinoma; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cialis (tadalafil)
• OPDIVO (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Lip, Oral Cavity and Pharynx, Larynx | EARLY_Phase 1 | Status: COMPLETED